Top Marketing News
How molecular biomarkers are transforming cancer treatment
AbbVie goes 3-0 in delaying Humira rivals
Drug lobby aims to shake up how medicines are paid for
Where does J&J’s new drug fit in the crowded HIV market?
5 drugs to watch as biotechs report Q2
FDA seeks to make more drugs available over the counter
Gilenya patent decision gives MS market a reprieve… Read More BioPharma Dive: Marketing | July 18 | AbbVie delays another Humira rival | PhRMA proposes rebate shake-up